Skip to content
RNA Diagnostics Logo
  • Home
  • About
    • About RNA Diagnostics
    • Our Team
    • Supported By
  • RDA™
  • Physicians
    • What is RDA™
    • How does RDA™ work?
    • RDA™ in Clinical Practice
  • BREVITY
  • News
    • News
    • Publications
  • Contact

Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners

By RNA Diagnostics|2018-12-03T18:53:28+00:00November 8th, 2018|Uncategorized|

Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced today the closing [...]

Read More
Comments Off on Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners

Rna Diagnostics Aims for 2020 Clinical Launch of Breast Cancer Treatment Guidance Test

By RNA Diagnostics|2018-12-02T20:53:21+00:00May 24th, 2018|Uncategorized|

NEW YORK (GenomeWeb) Rna Diagnostics, a Canadian molecular diagnostics company, recently commenced a clinical trial to validate an assay it [...]

Read More
Comments Off on Rna Diagnostics Aims for 2020 Clinical Launch of Breast Cancer Treatment Guidance Test

First patient enrolled in BREVITY, Rna Diagnostics’ International Validation Trial of RDA™ in Primary Breast Cancer

By RNA Diagnostics|2018-12-03T18:53:28+00:00April 27th, 2018|Uncategorized|

Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced enrollment of the [...]

Read More
Comments Off on First patient enrolled in BREVITY, Rna Diagnostics’ International Validation Trial of RDA™ in Primary Breast Cancer

Rna Diagnostics Inc. appoints Dr. Matthew P. Goetz to Clinical Advisory Board

By RNA Diagnostics|2018-12-03T18:53:28+00:00July 6th, 2017|Uncategorized|

  Rna Diagnostics Inc. announced today that Dr. Matthew P. Goetz, Consultant and Professor at Mayo Clinic, Rochester, MN has [...]

Read More
Comments Off on Rna Diagnostics Inc. appoints Dr. Matthew P. Goetz to Clinical Advisory Board

Rna Diagnostics Launches BREVITY – International Validation Trial of RDA™ in Breast Cancer

By RNA Diagnostics|2018-12-03T18:53:28+00:00June 14th, 2017|Uncategorized|

Rna Diagnostics announced the launch of an international prospective clinical trial to validate the RNA Disruption Assay™ (RDA™) as a [...]

Read More
Comments Off on Rna Diagnostics Launches BREVITY – International Validation Trial of RDA™ in Breast Cancer

Further evidence RDA™ may predict clinical outcome of chemotherapy in Journal of the National Cancer Institute

By RNA Diagnostics|2018-12-03T18:53:28+00:00September 15th, 2016|Uncategorized|

A new study provides further evidence that the Rna Disruption Assay™ (RDA™) may be a useful tool to predict the [...]

Read More
Comments Off on Further evidence RDA™ may predict clinical outcome of chemotherapy in Journal of the National Cancer Institute

Rna Diagnostics Inc. appoints Dr. Jeremy Bridge-Cook President and CEO

By RNA Diagnostics|2018-12-03T18:53:28+00:00April 1st, 2016|Uncategorized|

Rna Diagnostics Inc. appoints Dr. Jeremy Bridge-Cook President and CEO Dr. Ken Pritzker, on behalf of the Board of Directors [...]

Read More
Comments Off on Rna Diagnostics Inc. appoints Dr. Jeremy Bridge-Cook President and CEO

RNA Disruption is a major biologic mechanism induced by multiple classes of chemotherapy drugs

By RNA Diagnostics|2018-12-03T18:53:28+00:00March 10th, 2016|Uncategorized|

Rna Diagnostics announces the publication of a study on February 24 2016 in the journal BMC Cancer entitled RNA disruption is [...]

Read More
Comments Off on RNA Disruption is a major biologic mechanism induced by multiple classes of chemotherapy drugs

Paul Lucas joins the Board of Directors at Rna Diagnostics Inc.

By RNA Diagnostics|2018-12-03T18:53:28+00:00February 18th, 2016|Uncategorized|

Rna Diagnostics Inc. announced today that Paul Lucas, an accomplished veteran of the Life Sciences industry, has joined the Company’s [...]

Read More
Comments Off on Paul Lucas joins the Board of Directors at Rna Diagnostics Inc.

Rna Diagnostics “Breaking the Mold” at World Cancer Day event hosted by the Ontario Institute for Cancer Research and MaRS

By RNA Diagnostics|2018-12-03T18:53:28+00:00February 12th, 2016|Uncategorized|

The Ontario Institute for Cancer Research and MaRS Discovery District hosted an event for World Cancer Day under the banner [...]

Read More
Comments Off on Rna Diagnostics “Breaking the Mold” at World Cancer Day event hosted by the Ontario Institute for Cancer Research and MaRS
12Next
newsletter

Keep updated with our latest news

* indicates required
Subscribe to our news updates

Recent News

  • Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners
© 2017 Rna Diagnostics Inc. | rnadiagnostics.com
Twitter